JP2011503137A5 - - Google Patents

Download PDF

Info

Publication number
JP2011503137A5
JP2011503137A5 JP2010533548A JP2010533548A JP2011503137A5 JP 2011503137 A5 JP2011503137 A5 JP 2011503137A5 JP 2010533548 A JP2010533548 A JP 2010533548A JP 2010533548 A JP2010533548 A JP 2010533548A JP 2011503137 A5 JP2011503137 A5 JP 2011503137A5
Authority
JP
Japan
Prior art keywords
vitro
interleukin
incubating
analogues
microorganism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010533548A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011503137A (ja
Filing date
Publication date
Priority claimed from EP07120713A external-priority patent/EP2060586A1/en
Application filed filed Critical
Publication of JP2011503137A publication Critical patent/JP2011503137A/ja
Publication of JP2011503137A5 publication Critical patent/JP2011503137A5/ja
Pending legal-status Critical Current

Links

JP2010533548A 2007-11-14 2008-11-10 新規のアルギニン置換ペプチド及びその使用 Pending JP2011503137A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07120713A EP2060586A1 (en) 2007-11-14 2007-11-14 New synthetic arginine substituted peptides and their use
US99006607P 2007-11-26 2007-11-26
PCT/EP2008/065186 WO2009062898A1 (en) 2007-11-14 2008-11-10 New synthetic arginine substituted peptides and their use

Publications (2)

Publication Number Publication Date
JP2011503137A JP2011503137A (ja) 2011-01-27
JP2011503137A5 true JP2011503137A5 (enExample) 2012-01-05

Family

ID=39226731

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010533548A Pending JP2011503137A (ja) 2007-11-14 2008-11-10 新規のアルギニン置換ペプチド及びその使用

Country Status (9)

Country Link
US (2) US7928185B2 (enExample)
EP (2) EP2060586A1 (enExample)
JP (1) JP2011503137A (enExample)
CN (1) CN101878226B (enExample)
AU (1) AU2008323041A1 (enExample)
CA (1) CA2703894A1 (enExample)
DK (1) DK2212352T3 (enExample)
MX (1) MX2010005280A (enExample)
WO (1) WO2009062898A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2481751A1 (en) * 2011-01-26 2012-08-01 PharmaSurgics in Sweden AB Human lactoferrin derived peptides
EP2931896B1 (en) * 2012-12-11 2019-01-16 Osivax SAS Modified coiled coil type proteins having improved properties
CN105143251B (zh) 2013-03-18 2021-05-11 奥西瓦科斯公司 流感核蛋白疫苗
EP2989120A4 (en) * 2013-04-25 2017-04-19 Carmel-Haifa University Economic Corp. Synthetic anti-inflammatory peptides and use thereof
WO2020096672A1 (en) 2018-11-09 2020-05-14 The Wistar Institute Of Anatomy And Biology Use of lactoferrin for generating myeloid-derived suppressor cells

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2818056B2 (ja) 1990-09-07 1998-10-30 森永乳業株式会社 抗菌性ペプチドおよび抗菌剤
EP0629347B1 (en) 1992-01-23 1997-07-02 Morinaga Milk Industry Co., Ltd. Antibacterial agent and treatment of article therewith
JP3347819B2 (ja) 1993-06-28 2002-11-20 森永乳業株式会社 抗菌性ペプチドの精製方法
JP3529423B2 (ja) 1994-04-01 2004-05-24 森永乳業株式会社 抗菌性ペプチドの製造方法
JP3812957B2 (ja) 1994-08-02 2006-08-23 森永乳業株式会社 角膜損傷治療剤
JPH08143468A (ja) 1994-11-17 1996-06-04 Morinaga Milk Ind Co Ltd 抗潰瘍剤
WO1998006425A1 (en) 1996-08-12 1998-02-19 A+ Science Invest Ab Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin
SE9804614A0 (en) * 1998-07-06 2000-01-07 A+ Science Invest Ab New peptides and use thereof
US6399570B1 (en) 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
JP2003521483A (ja) * 1999-11-11 2003-07-15 エイエム ファーマ ビーブイ ヒトラクトフェリンの第1カチオンクラスターの抗菌活性
WO2006047744A2 (en) 2004-10-26 2006-05-04 Agennix Incorporated Compositions of lactoferrin related peptides and uses thereof

Similar Documents

Publication Publication Date Title
Osei et al. Current perspectives on the role of interleukin-1 signalling in the pathogenesis of asthma and COPD
JP2011503137A5 (enExample)
ES2496972T3 (es) Método para criar ácaros depredadores
Tanabe et al. Airway goblet cells secrete pro-inflammatory cytokines, chemokines, and growth factors
JP2006514034A5 (enExample)
Sayers et al. Role of cyclooxygenase-2 in exacerbation of allergen-induced airway remodeling by multiwalled carbon nanotubes
CN104278077B (zh) 一种高通量快速筛选罗氏沼虾免疫增强剂的方法
CN203928187U (zh) 一种畜牧养殖业空气净化装置
CN112106705B (zh) 一种评价药物预防病毒性肺炎效果的方法
Górska et al. Airway inflammation in chronic obstructive pulmonary disease
Lora et al. FcεRI-dependent gene expression in human mast cells is differentially controlled by T helper type 2 cytokines
Perez Gutierrez et al. Anti-inflammatory effect of procumbenoside B from Justicia spicigera on lipopolysaccharide-stimulated RAW 264.7 macrophages and zebrafish model.
Babiceanu et al. Analysis of global gene expression changes in human bronchial epithelial cells exposed to spores of the allergenic fungus, Alternaria alternata
Xiang et al. Grancalcin Hydrogel Microneedle Patches Alleviate Sepsis via Modulation of Calcium Signaling to Augment Immune Cell Phagocytosis
CN105412112A (zh) Roquefortine F在制备治疗慢性阻塞性肺疾病药物中的应用
CN102154185B (zh) 一株产咖啡酸的刺五加内生细菌
Lee et al. Evidence-guided optimization of herbal formula Cheong-Hwa-Bo-Um-Tang using multiplex cytokine profiling
sites Prevalence et al. First reported detection of Batrachochytrium dendrobatidis in Florida, USA
CN119827767B (zh) 泛素特异性蛋白酶usp4在治疗急性肺损伤/急性呼吸窘迫综合征中的应用
CN204540371U (zh) 从王台中取幼虫的多排镊子
CHO et al. Comparison of Cytokine and Chemokine Production and Activation of NF-kappaB in RSV-and Adenovirus-infected Bronchial Epithelial Cells
CN102988377B (zh) Houttuynoid D在制备治疗慢性阻塞性肺疾病的药物中的应用
Lagadinou et al. Alterations in cytokine measurements in ascitic fluid of cirrhotic patients with and without spontaneous bacterial peritonitis
CN102988383B (zh) Houttuynoid E在制备治疗慢性阻塞性肺疾病的药物中的应用
FAN et al. Effects of Compound Glycyrrhizin on Chemotactic Factors' Expression in Peripheral Blood Mononuclear Cells